AI assistant
Sending…
UMB FINANCIAL CORP — Director's Dealing 2023
Aug 31, 2023
30657_dirs_2023-08-31_059c8e70-eb02-4de2-b726-31750575e27d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UMB FINANCIAL CORP (UMBF)
CIK: 0000101382
Period of Report: 2023-08-30
Reporting Person: KEMPER J MARINER (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | Common Stock | S | 959 | $63.60 | Disposed | 1876667 | Indirect |
| 2023-08-30 | Common Stock | S | 300 | $63.64 | Disposed | 1876367 | Indirect |
| 2023-08-30 | Common Stock | S | 804 | $63.65 | Disposed | 1875563 | Indirect |
| 2023-08-30 | Common Stock | S | 296 | $63.69 | Disposed | 1875267 | Indirect |
| 2023-08-30 | Common Stock | S | 438 | $63.76 | Disposed | 1874829 | Indirect |
| 2023-08-30 | Common Stock | S | 199 | $63.78 | Disposed | 1874630 | Indirect |
| 2023-08-30 | Common Stock | S | 365 | $63.80 | Disposed | 1874265 | Indirect |
| 2023-08-30 | Common Stock | S | 201 | $63.83 | Disposed | 1874064 | Indirect |
| 2023-08-30 | Common Stock | S | 176 | $63.87 | Disposed | 1873888 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 236398.3197 | Direct |
| Common Stock | 1000 | Indirect |
| Common Stock | 2132.9316 | Indirect |
| Common Stock | 1000 | Indirect |
| Common Stock | 29960 | Indirect |
| Common Stock | 12558 | Indirect |
| Common Stock | 290397 | Indirect |
| Common Stock | 395989 | Indirect |
More from UMB FINANCIAL CORP
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 24
Proxy Solicitation & Information Statement
2026
Mar 12
Annual Report
2026
Feb 26